SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
<< first | < prev
page:
of 3
|
records per page:
next >
| last >>
|
pages: 1 2 3
|
presentations:
1 to
50 of
102
|
PrEP for HIV Prevention: What We Know and What We Still Need to Know for Implementation
Raphael J. Landovitz
University of California Los Angeles, Los Angeles, CA, United States
Specific HIV Integration Sites Linked to Clonal Expansion and Persistence of Cells
Stephen H. Hughes
National Cancer Institute, Frederick, MD, United States
Envelope Trimer Numbers Required for Entry Steer HIV-1 Infectivity and Entry Kinetics
Alexandra Trkola
University of Zurich, Zurich, Switzerland
HIV-1 Accessory Protein Function: Evaluating VPU-Dependent Host Factor Degradation
Prashant Jain
Sanford-Burnham Medical Research Institute, La Jolla, CA, United States
HIV-1 Adaptation to Humans Involved Interactions of Vpr With the DNA Damage Response
Oliver I. Fregoso
Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, United States
The HIV-1 Protease Can Interact With RNA to Dramatically Enhance Its Activity
Marc Potempa
University of North Carolina, Chapel Hill, NC
PQBP1 Is a Retrovirus-Specific Sensor Mediating cGAS/IRF3-Dependent Innate Responses
Sunnie M. Yoh
Sanford-Burnham Medical Research Institute, La Jolla, CA, United States
Mucosal HIV-1 Transmission Specifically Selects for Type 1 Interferon-Resistant Viruses
Shilpa Iyer
University of Pennsylvania, Philadelphia, PA, United States
The Dynamics of HIV-1 RNA Near the Plasma Membrane During Virus Assembly
Luca Sardo
Frederick National Laboratory for Cancer Research, Frederick, MD, United States
Mechanisms of Dendritic Cell-Mediated Transfer of HIV-1 to CD4+ T Lymphocytes
Mickael M. Menager
Skirball Institute of Biomolecular Medicine, New York, NY, United States
Inflammation Persists Despite Early Initiation of ART in Acute HIV Infection
Netanya S. Utay
University of Texas Medical Branch at Galveston, Galveston, TX, United States
HIV Burden and Biomarker Associations With Colonic HIV RNA During Acute HIV Infection
Trevor A. Crowell
US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States
Identification and Characterization of Individual HIV-Infected CD4 T Cells Ex Vivo
Joseph Casazza
Vaccine Research Center, NIAID, NIH, Bethesda, MD, United States
Efficacy of HIV-1 Monoclonal Antibody Immunotherapy in Acute SHIV-Infected Macaques
Diane L. Bolton
US Military HIV Research Program, Silver Spring, MD, United States
HIV-1 Infections With Multiple Founders Are Associated With Higher Viral Loads
Morgane Rolland
US Military HIV Research Program, Silver Spring, MD, United States
Post-Treatment Controllers Have Particular NK Cells With High Anti-HIV Capacity: VISCONTI Study
Daniel Scott-Algara
Institut Pasteur, Paris, France
Antiretroviral Therapy Preserves Polyfunctional HIV-1–Specific CD8 T Cells With Stem-Cell–Like Properties
Selena Vigano
The Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
In Vitro Replication and Interferon-Alpha Resistance of Transmitted HIV-1 Variants
Zachary Ende
Emory University, Atlanta, GA, United States
HVTN505 Breakthrough Sequences Show HIV Vaccine-Associated Differences in Env-gp120
Morgane Rolland
US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Silver Spring, MD, United States
Pragmatic Open-Label Randomised Trial of Preexposure Prophylaxis: The PROUD Study
Sheena McCormack
MRC Clinical Trials Unit at University College London, London, United Kingdom
On Demand PrEP With Oral TDF-FTC in MSM: Results of the ANRS Ipergay Trial
Jean-Michel Molina
University of Paris Diderot, Paris, France
Near Elimination of HIV Transmission in a Demonstration Project of PrEP and ART
Jared Baeten
University of Washington, Seattle, WA, United States
Scale-Up of Preexposure Prophylaxis in San Francisco to Impact HIV Incidence
Robert M. Grant
Gladstone Institutes, San Francisco, CA, United States
FACTS 001 Phase III Trial of Pericoital Tenofovir 1% Gel for HIV Prevention in Women
Helen Rees
Wits Reproductive Health and HIV Institute, Johannesburg, South Africa
Effect of Oral and Gel Tenofovir on Genital HSV Shedding in Immunocompetent Women
Rachel A. Bender Ignacio
University of Washington, Seattle, WA, United States
Injectable Hormonal Contraception Use and Women's Risk for HSV-2 Acquisition
Mary K. Grabowski
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
Effect of Financial Incentives on Linkage to Care and Viral Suppression: HPTN 065
Wafaa M. El-Sadr
ICAP at Columbia University, New York, NY, United States
Medical Male Circumcision of HIV-Infected Men Reduces Long-Term Penile HIV Shedding
Jordyn L. Manucci
Johns Hopkins University School of Medicine, Baltimore, MD, United States
PROMISE: Efficacy and Safety of 2 Strategies to Prevent Perinatal HIV Transmission
Mary Glenn Fowler
Johns Hopkins University School of Medicine/Makerere University–Johns Hopkins University Research Collaboration, Baltimore, MD, United States
Most Breastfeeding Women With High Viral Load Are Still Undiagnosed in Sub-Saharan Africa
David Maman
Epicentre/Médecins Sans Frontières, Paris, France
Delayed HIV Detection in Infants Exposed to ARV Prophylaxis During Breastfeeding
Caroline C. King
US Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States
Evaluation of the Alere q for Point-of-Care Early Infant HIV Diagnosis in South Africa
Nei-Yuan Hsiao
University of Cape Town, Cape Town, South Africa
Early ART and Sustained Virological Suppression Limits HIV Proviral DNA Reservoir: CHER Evidence
Helen A. Payne
University College London, London, United Kingdom
Long-Term Outcomes of HIV-Infected Children Initiating NVP vs LPV/r-Based Treatment
Linda Barlow-Mosha
Makerere University–Johns Hopkins University Research Collaboration, Kampala, Uganda
Structural Cardiovascular Changes Are Reversible in HIV-Infected Children in Zambia and Uganda.
Julia M. Kenny
University College London, London, United Kingdom
ART With Weekends Off Is Noninferior to Continuous ART in Young People on EFV+2NRTI
Karina M. Butler
Our Lady's Children's Hospital, Dublin, Ireland
Discussion Leader
Emmanuel Njeuhmeli
US Agency for International Development, Douglasville, GA, United States
Mobile VMMC Teams in Tanzania See Older Clients and Have Higher Followup Rates
Augustino M. Hellar
Jhpiego, Dar es Salaam, United Republic of Tanzania
High Acceptability of PrePex™ Device in Routine Programmatic Settings in Rwanda
Eugene Rugwizangoga
Jhpiego/Rwanda, Kigali, Rwanda
Potential Protection From HIV Transmission by Penile Cuttings in Papua New Guinea
Ivy H. Shih
The Kirby Institute, Sydney, Australia
HSV-2 Shedding From Male Circumcision Wounds Among HIV-Infected Men
Mary K. Grabowski
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
Self-Selection of Circumcision Acceptors, Risk Compensation and Effectiveness of Circumcision Among Service Recipients, Rakai, Uganda
Joseph Kagaayi
Rakai Health Sciences Program, Entebbe, Uganda
Discussion Leader
Miriam Rabkin
Columbia University Mailman School of Public Health, Chapel Hill, NC, United States
Obesity and Inflammation in Resource-Diverse Settings of ART Initiation
Kristine M. Erlandson
University of Colorado, Aurora, CO, United States
Body Composition Outcomes at 96 Weeks in the SECOND-LINE RCT DXA Substudy
Mark A. Boyd
University of New South Wales Australia, Sydney, Australia
Bone Quality by Quantitative Ultrasound at the Radius Does Not Differ in ART-Naïve HIV+ and HIV- Rwandan Women
Eugene Mutimura
Regional Alliance for Sustainable Development, Kigali, Rwanda
Predictors and Outcomes of Incident High Cholesterol in Adults on ART in South Africa
Matt P. Fox
Boston University, Boston, MA, United States
Metabolic Changes and Second-Line ART in Africa (2LADY/ANRS 12169 Trial)
Amandine Cournil
IRD/UM 1, Montpellier, France
<< first | < prev
page:
of 3
|
records per page:
next >
| last >>
|
pages: 1 2 3
|
presentations:
1 to
50 of
102
|